total antioxidant capacity (tac) Search Results


90
Cayman Chemical serum total antioxidant capacity (tac) kit
Effect of berberine administration to the diabetic rats on the total <t>antioxidant</t> capacity <t>(TAC)</t> in the serum. The results are presented as an arithmetical mean ± SEM. The statistical significance of the results was evaluated by ANOVA followed by Tukey’s honestly significant difference (HSD) post-hoc test. The results were considered statistically significant if p < 0.05: * p < 0.05—statistically significant difference in comparison with the NDM group; ### p < 0.001—statistically significant difference between the DM + BRB and DM groups. NDM: non-diabetic control rats, DM: diabetic control rats, DM + BRB: diabetic rats treated with berberine at a dose of 50 mg/kg per os (p.o.) for four weeks.
Serum Total Antioxidant Capacity (Tac) Kit, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/serum total antioxidant capacity (tac) kit/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
serum total antioxidant capacity (tac) kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioDiagnostics Inc total antioxidant capacity (tac)
Effect of stem cell treatment on biochemical markers. A Western blot analyses of IL-6 and RhoA in lung tissue in all groups. β actin was used for normalization. Images of the bands where obtained from the same gel with no cropping in between the bands. Full length blots are included in the Additional file Fig. S1. B , C Representative graphs for relative expression of IL-6 and RhoA respectively. D , E Representative graphs for quantification of MDA and <t>TAC</t> in lung tissue of all experimental groups. Data is represented in mean. n = 3 in all groups. a; significant compared to CG. b: significant compared to HG. c: significant compared to CFM-G. d: significant compared to SC-PG. e: significant compared to SC-TG. Pairwise comparison bet. Each 2 groups using Post Hoc Test (Tukey). Significance at p ≤ 0.05. Error bars represent S.E.M. Stem cell treatment significantly reduced IL-6, RhoA and increased TAC, while stem cell prophylaxis significantly reduced MDA. Abbreviations: CG; control group, HG; Hyperoxia group, CFM-G; Cell-free media-treated group, SC-PG; Stem cells-prophylactic group, SC-TG; Stem cells-treated group, Unt-G Untreated group, IL-6; interleukin 6, RhoA; Ras homolog family member A, MDA; malondialdehyde, TAC; total <t>antioxidant</t> capacity
Total Antioxidant Capacity (Tac), supplied by BioDiagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/total antioxidant capacity (tac)/product/BioDiagnostics Inc
Average 90 stars, based on 1 article reviews
total antioxidant capacity (tac) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cell Biolabs Inc oxiselect cellular antioxidant assay kit
Effect of stem cell treatment on biochemical markers. A Western blot analyses of IL-6 and RhoA in lung tissue in all groups. β actin was used for normalization. Images of the bands where obtained from the same gel with no cropping in between the bands. Full length blots are included in the Additional file Fig. S1. B , C Representative graphs for relative expression of IL-6 and RhoA respectively. D , E Representative graphs for quantification of MDA and <t>TAC</t> in lung tissue of all experimental groups. Data is represented in mean. n = 3 in all groups. a; significant compared to CG. b: significant compared to HG. c: significant compared to CFM-G. d: significant compared to SC-PG. e: significant compared to SC-TG. Pairwise comparison bet. Each 2 groups using Post Hoc Test (Tukey). Significance at p ≤ 0.05. Error bars represent S.E.M. Stem cell treatment significantly reduced IL-6, RhoA and increased TAC, while stem cell prophylaxis significantly reduced MDA. Abbreviations: CG; control group, HG; Hyperoxia group, CFM-G; Cell-free media-treated group, SC-PG; Stem cells-prophylactic group, SC-TG; Stem cells-treated group, Unt-G Untreated group, IL-6; interleukin 6, RhoA; Ras homolog family member A, MDA; malondialdehyde, TAC; total <t>antioxidant</t> capacity
Oxiselect Cellular Antioxidant Assay Kit, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oxiselect cellular antioxidant assay kit/product/Cell Biolabs Inc
Average 90 stars, based on 1 article reviews
oxiselect cellular antioxidant assay kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AAT Bioquest total antioxidant capacity (tac) assay kit cell metertm colorimetric antioxidant activity assay kit, # 15900
Effect of stem cell treatment on biochemical markers. A Western blot analyses of IL-6 and RhoA in lung tissue in all groups. β actin was used for normalization. Images of the bands where obtained from the same gel with no cropping in between the bands. Full length blots are included in the Additional file Fig. S1. B , C Representative graphs for relative expression of IL-6 and RhoA respectively. D , E Representative graphs for quantification of MDA and <t>TAC</t> in lung tissue of all experimental groups. Data is represented in mean. n = 3 in all groups. a; significant compared to CG. b: significant compared to HG. c: significant compared to CFM-G. d: significant compared to SC-PG. e: significant compared to SC-TG. Pairwise comparison bet. Each 2 groups using Post Hoc Test (Tukey). Significance at p ≤ 0.05. Error bars represent S.E.M. Stem cell treatment significantly reduced IL-6, RhoA and increased TAC, while stem cell prophylaxis significantly reduced MDA. Abbreviations: CG; control group, HG; Hyperoxia group, CFM-G; Cell-free media-treated group, SC-PG; Stem cells-prophylactic group, SC-TG; Stem cells-treated group, Unt-G Untreated group, IL-6; interleukin 6, RhoA; Ras homolog family member A, MDA; malondialdehyde, TAC; total <t>antioxidant</t> capacity
Total Antioxidant Capacity (Tac) Assay Kit Cell Metertm Colorimetric Antioxidant Activity Assay Kit, # 15900, supplied by AAT Bioquest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/total antioxidant capacity (tac) assay kit cell metertm colorimetric antioxidant activity assay kit, # 15900/product/AAT Bioquest
Average 90 stars, based on 1 article reviews
total antioxidant capacity (tac) assay kit cell metertm colorimetric antioxidant activity assay kit, # 15900 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Omnignostica GmbH tac fast track elisa kit no. ldn-dm p-4100
Effect of stem cell treatment on biochemical markers. A Western blot analyses of IL-6 and RhoA in lung tissue in all groups. β actin was used for normalization. Images of the bands where obtained from the same gel with no cropping in between the bands. Full length blots are included in the Additional file Fig. S1. B , C Representative graphs for relative expression of IL-6 and RhoA respectively. D , E Representative graphs for quantification of MDA and <t>TAC</t> in lung tissue of all experimental groups. Data is represented in mean. n = 3 in all groups. a; significant compared to CG. b: significant compared to HG. c: significant compared to CFM-G. d: significant compared to SC-PG. e: significant compared to SC-TG. Pairwise comparison bet. Each 2 groups using Post Hoc Test (Tukey). Significance at p ≤ 0.05. Error bars represent S.E.M. Stem cell treatment significantly reduced IL-6, RhoA and increased TAC, while stem cell prophylaxis significantly reduced MDA. Abbreviations: CG; control group, HG; Hyperoxia group, CFM-G; Cell-free media-treated group, SC-PG; Stem cells-prophylactic group, SC-TG; Stem cells-treated group, Unt-G Untreated group, IL-6; interleukin 6, RhoA; Ras homolog family member A, MDA; malondialdehyde, TAC; total <t>antioxidant</t> capacity
Tac Fast Track Elisa Kit No. Ldn Dm P 4100, supplied by Omnignostica GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tac fast track elisa kit no. ldn-dm p-4100/product/Omnignostica GmbH
Average 90 stars, based on 1 article reviews
tac fast track elisa kit no. ldn-dm p-4100 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology tac kit
Effect of stem cell treatment on biochemical markers. A Western blot analyses of IL-6 and RhoA in lung tissue in all groups. β actin was used for normalization. Images of the bands where obtained from the same gel with no cropping in between the bands. Full length blots are included in the Additional file Fig. S1. B , C Representative graphs for relative expression of IL-6 and RhoA respectively. D , E Representative graphs for quantification of MDA and <t>TAC</t> in lung tissue of all experimental groups. Data is represented in mean. n = 3 in all groups. a; significant compared to CG. b: significant compared to HG. c: significant compared to CFM-G. d: significant compared to SC-PG. e: significant compared to SC-TG. Pairwise comparison bet. Each 2 groups using Post Hoc Test (Tukey). Significance at p ≤ 0.05. Error bars represent S.E.M. Stem cell treatment significantly reduced IL-6, RhoA and increased TAC, while stem cell prophylaxis significantly reduced MDA. Abbreviations: CG; control group, HG; Hyperoxia group, CFM-G; Cell-free media-treated group, SC-PG; Stem cells-prophylactic group, SC-TG; Stem cells-treated group, Unt-G Untreated group, IL-6; interleukin 6, RhoA; Ras homolog family member A, MDA; malondialdehyde, TAC; total <t>antioxidant</t> capacity
Tac Kit, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tac kit/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
tac kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Diametra SRL total antioxidant capacity (tac) measurement kit
Effect of stem cell treatment on biochemical markers. A Western blot analyses of IL-6 and RhoA in lung tissue in all groups. β actin was used for normalization. Images of the bands where obtained from the same gel with no cropping in between the bands. Full length blots are included in the Additional file Fig. S1. B , C Representative graphs for relative expression of IL-6 and RhoA respectively. D , E Representative graphs for quantification of MDA and <t>TAC</t> in lung tissue of all experimental groups. Data is represented in mean. n = 3 in all groups. a; significant compared to CG. b: significant compared to HG. c: significant compared to CFM-G. d: significant compared to SC-PG. e: significant compared to SC-TG. Pairwise comparison bet. Each 2 groups using Post Hoc Test (Tukey). Significance at p ≤ 0.05. Error bars represent S.E.M. Stem cell treatment significantly reduced IL-6, RhoA and increased TAC, while stem cell prophylaxis significantly reduced MDA. Abbreviations: CG; control group, HG; Hyperoxia group, CFM-G; Cell-free media-treated group, SC-PG; Stem cells-prophylactic group, SC-TG; Stem cells-treated group, Unt-G Untreated group, IL-6; interleukin 6, RhoA; Ras homolog family member A, MDA; malondialdehyde, TAC; total <t>antioxidant</t> capacity
Total Antioxidant Capacity (Tac) Measurement Kit, supplied by Diametra SRL, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/total antioxidant capacity (tac) measurement kit/product/Diametra SRL
Average 90 stars, based on 1 article reviews
total antioxidant capacity (tac) measurement kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ZellBio GmbH total oxidant capacity (toc) kit
<t>TNF-α,</t> TAC and <t>TOC</t> levels in SHAM, EXP, HI and HI/EXP groups. (a) * p < 0.0001, HI vs. SHAM; ** p < 0.001, HI vs. EXP; # p < 0.0001 HI/EXP vs. SHAM and EXP; ## p < 0.01, HI/EXP vs. HI. (b) * P < 0.0001, HI vs. SHAM; ** P < 0.01, HI vs. EXP; # P < 0.0001 HI/EXP vs. SHAM and EXP; ## P < 0.01 HI/EXP vs. HI (c) * p < 0.001, HI vs. SHAM; ** p < 0.01, HI vs. EXP; # p < 0.0001, HI/EXP vs. SHAM and EXP; ## P < 0.01, HI/EXP vs. HI. TNF-α (Tumour necrosis factor α), TAC (Total antioxidant capacity), TOC (Total oxidant capacity), EXP (exposure), HI (hypoxia-ischemia), HI/EXP (hypoxia-ischemia/exposure).
Total Oxidant Capacity (Toc) Kit, supplied by ZellBio GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/total oxidant capacity (toc) kit/product/ZellBio GmbH
Average 90 stars, based on 1 article reviews
total oxidant capacity (toc) kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Diacron Labs serum reactive oxygen species levels
<t>TNF-α,</t> TAC and <t>TOC</t> levels in SHAM, EXP, HI and HI/EXP groups. (a) * p < 0.0001, HI vs. SHAM; ** p < 0.001, HI vs. EXP; # p < 0.0001 HI/EXP vs. SHAM and EXP; ## p < 0.01, HI/EXP vs. HI. (b) * P < 0.0001, HI vs. SHAM; ** P < 0.01, HI vs. EXP; # P < 0.0001 HI/EXP vs. SHAM and EXP; ## P < 0.01 HI/EXP vs. HI (c) * p < 0.001, HI vs. SHAM; ** p < 0.01, HI vs. EXP; # p < 0.0001, HI/EXP vs. SHAM and EXP; ## P < 0.01, HI/EXP vs. HI. TNF-α (Tumour necrosis factor α), TAC (Total antioxidant capacity), TOC (Total oxidant capacity), EXP (exposure), HI (hypoxia-ischemia), HI/EXP (hypoxia-ischemia/exposure).
Serum Reactive Oxygen Species Levels, supplied by Diacron Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/serum reactive oxygen species levels/product/Diacron Labs
Average 90 stars, based on 1 article reviews
serum reactive oxygen species levels - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioCore Inc total antioxidant capacity (tac) and glutathione (gsh) levels
<t>TNF-α,</t> TAC and <t>TOC</t> levels in SHAM, EXP, HI and HI/EXP groups. (a) * p < 0.0001, HI vs. SHAM; ** p < 0.001, HI vs. EXP; # p < 0.0001 HI/EXP vs. SHAM and EXP; ## p < 0.01, HI/EXP vs. HI. (b) * P < 0.0001, HI vs. SHAM; ** P < 0.01, HI vs. EXP; # P < 0.0001 HI/EXP vs. SHAM and EXP; ## P < 0.01 HI/EXP vs. HI (c) * p < 0.001, HI vs. SHAM; ** p < 0.01, HI vs. EXP; # p < 0.0001, HI/EXP vs. SHAM and EXP; ## P < 0.01, HI/EXP vs. HI. TNF-α (Tumour necrosis factor α), TAC (Total antioxidant capacity), TOC (Total oxidant capacity), EXP (exposure), HI (hypoxia-ischemia), HI/EXP (hypoxia-ischemia/exposure).
Total Antioxidant Capacity (Tac) And Glutathione (Gsh) Levels, supplied by BioCore Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/total antioxidant capacity (tac) and glutathione (gsh) levels/product/BioCore Inc
Average 90 stars, based on 1 article reviews
total antioxidant capacity (tac) and glutathione (gsh) levels - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Avicenna Research antioxidant capacity (tac)
<t>TNF-α,</t> TAC and <t>TOC</t> levels in SHAM, EXP, HI and HI/EXP groups. (a) * p < 0.0001, HI vs. SHAM; ** p < 0.001, HI vs. EXP; # p < 0.0001 HI/EXP vs. SHAM and EXP; ## p < 0.01, HI/EXP vs. HI. (b) * P < 0.0001, HI vs. SHAM; ** P < 0.01, HI vs. EXP; # P < 0.0001 HI/EXP vs. SHAM and EXP; ## P < 0.01 HI/EXP vs. HI (c) * p < 0.001, HI vs. SHAM; ** p < 0.01, HI vs. EXP; # p < 0.0001, HI/EXP vs. SHAM and EXP; ## P < 0.01, HI/EXP vs. HI. TNF-α (Tumour necrosis factor α), TAC (Total antioxidant capacity), TOC (Total oxidant capacity), EXP (exposure), HI (hypoxia-ischemia), HI/EXP (hypoxia-ischemia/exposure).
Antioxidant Capacity (Tac), supplied by Avicenna Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antioxidant capacity (tac)/product/Avicenna Research
Average 90 stars, based on 1 article reviews
antioxidant capacity (tac) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Immundiagnostik AG total antioxidant capacity (tac) assay kit
<t>TNF-α,</t> TAC and <t>TOC</t> levels in SHAM, EXP, HI and HI/EXP groups. (a) * p < 0.0001, HI vs. SHAM; ** p < 0.001, HI vs. EXP; # p < 0.0001 HI/EXP vs. SHAM and EXP; ## p < 0.01, HI/EXP vs. HI. (b) * P < 0.0001, HI vs. SHAM; ** P < 0.01, HI vs. EXP; # P < 0.0001 HI/EXP vs. SHAM and EXP; ## P < 0.01 HI/EXP vs. HI (c) * p < 0.001, HI vs. SHAM; ** p < 0.01, HI vs. EXP; # p < 0.0001, HI/EXP vs. SHAM and EXP; ## P < 0.01, HI/EXP vs. HI. TNF-α (Tumour necrosis factor α), TAC (Total antioxidant capacity), TOC (Total oxidant capacity), EXP (exposure), HI (hypoxia-ischemia), HI/EXP (hypoxia-ischemia/exposure).
Total Antioxidant Capacity (Tac) Assay Kit, supplied by Immundiagnostik AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/total antioxidant capacity (tac) assay kit/product/Immundiagnostik AG
Average 90 stars, based on 1 article reviews
total antioxidant capacity (tac) assay kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Effect of berberine administration to the diabetic rats on the total antioxidant capacity (TAC) in the serum. The results are presented as an arithmetical mean ± SEM. The statistical significance of the results was evaluated by ANOVA followed by Tukey’s honestly significant difference (HSD) post-hoc test. The results were considered statistically significant if p < 0.05: * p < 0.05—statistically significant difference in comparison with the NDM group; ### p < 0.001—statistically significant difference between the DM + BRB and DM groups. NDM: non-diabetic control rats, DM: diabetic control rats, DM + BRB: diabetic rats treated with berberine at a dose of 50 mg/kg per os (p.o.) for four weeks.

Journal: International Journal of Molecular Sciences

Article Title: Effect of Berberine on Glycation, Aldose Reductase Activity, and Oxidative Stress in the Lenses of Streptozotocin-Induced Diabetic Rats In Vivo—A Preliminary Study

doi: 10.3390/ijms21124278

Figure Lengend Snippet: Effect of berberine administration to the diabetic rats on the total antioxidant capacity (TAC) in the serum. The results are presented as an arithmetical mean ± SEM. The statistical significance of the results was evaluated by ANOVA followed by Tukey’s honestly significant difference (HSD) post-hoc test. The results were considered statistically significant if p < 0.05: * p < 0.05—statistically significant difference in comparison with the NDM group; ### p < 0.001—statistically significant difference between the DM + BRB and DM groups. NDM: non-diabetic control rats, DM: diabetic control rats, DM + BRB: diabetic rats treated with berberine at a dose of 50 mg/kg per os (p.o.) for four weeks.

Article Snippet: The serum total antioxidant capacity (TAC) was evaluated with a commercially available Cayman kit.

Techniques: IF-P, Comparison, Control

Spearman’s r s correlation plot of biochemical parameters measured in the lenses and TAC in the serum; blue circles indicate positive correlations, red circles indicate negative correlations, both at p < 0.05; circles’ sizes correspond to correlation strength (the bigger the circle, the stronger the correlation). AGEs: advanced glycation end-products; AR: aldose reductase; SOD: superoxide dismutase; CAT: catalase; AOPP: advanced oxidation protein product; TBARS: thiobarbituric acid reactive substance; NPSH: non-protein sulfhydryl group; TAC: total antioxidant capacity.

Journal: International Journal of Molecular Sciences

Article Title: Effect of Berberine on Glycation, Aldose Reductase Activity, and Oxidative Stress in the Lenses of Streptozotocin-Induced Diabetic Rats In Vivo—A Preliminary Study

doi: 10.3390/ijms21124278

Figure Lengend Snippet: Spearman’s r s correlation plot of biochemical parameters measured in the lenses and TAC in the serum; blue circles indicate positive correlations, red circles indicate negative correlations, both at p < 0.05; circles’ sizes correspond to correlation strength (the bigger the circle, the stronger the correlation). AGEs: advanced glycation end-products; AR: aldose reductase; SOD: superoxide dismutase; CAT: catalase; AOPP: advanced oxidation protein product; TBARS: thiobarbituric acid reactive substance; NPSH: non-protein sulfhydryl group; TAC: total antioxidant capacity.

Article Snippet: The serum total antioxidant capacity (TAC) was evaluated with a commercially available Cayman kit.

Techniques:

Effect of stem cell treatment on biochemical markers. A Western blot analyses of IL-6 and RhoA in lung tissue in all groups. β actin was used for normalization. Images of the bands where obtained from the same gel with no cropping in between the bands. Full length blots are included in the Additional file Fig. S1. B , C Representative graphs for relative expression of IL-6 and RhoA respectively. D , E Representative graphs for quantification of MDA and TAC in lung tissue of all experimental groups. Data is represented in mean. n = 3 in all groups. a; significant compared to CG. b: significant compared to HG. c: significant compared to CFM-G. d: significant compared to SC-PG. e: significant compared to SC-TG. Pairwise comparison bet. Each 2 groups using Post Hoc Test (Tukey). Significance at p ≤ 0.05. Error bars represent S.E.M. Stem cell treatment significantly reduced IL-6, RhoA and increased TAC, while stem cell prophylaxis significantly reduced MDA. Abbreviations: CG; control group, HG; Hyperoxia group, CFM-G; Cell-free media-treated group, SC-PG; Stem cells-prophylactic group, SC-TG; Stem cells-treated group, Unt-G Untreated group, IL-6; interleukin 6, RhoA; Ras homolog family member A, MDA; malondialdehyde, TAC; total antioxidant capacity

Journal: Stem Cell Research & Therapy

Article Title: Potential effect of amniotic fluid-derived stem cells on hyperoxia-induced pulmonary alveolar injury

doi: 10.1186/s13287-022-02821-3

Figure Lengend Snippet: Effect of stem cell treatment on biochemical markers. A Western blot analyses of IL-6 and RhoA in lung tissue in all groups. β actin was used for normalization. Images of the bands where obtained from the same gel with no cropping in between the bands. Full length blots are included in the Additional file Fig. S1. B , C Representative graphs for relative expression of IL-6 and RhoA respectively. D , E Representative graphs for quantification of MDA and TAC in lung tissue of all experimental groups. Data is represented in mean. n = 3 in all groups. a; significant compared to CG. b: significant compared to HG. c: significant compared to CFM-G. d: significant compared to SC-PG. e: significant compared to SC-TG. Pairwise comparison bet. Each 2 groups using Post Hoc Test (Tukey). Significance at p ≤ 0.05. Error bars represent S.E.M. Stem cell treatment significantly reduced IL-6, RhoA and increased TAC, while stem cell prophylaxis significantly reduced MDA. Abbreviations: CG; control group, HG; Hyperoxia group, CFM-G; Cell-free media-treated group, SC-PG; Stem cells-prophylactic group, SC-TG; Stem cells-treated group, Unt-G Untreated group, IL-6; interleukin 6, RhoA; Ras homolog family member A, MDA; malondialdehyde, TAC; total antioxidant capacity

Article Snippet: The lung tissues were homogenized in 1–2 ml of 5 mM cold potassium phosphate buffer (pH 7.4), centrifuged at 4000 rpm for 15 min at 4 °C and the supernatant was removed and stored at − 80 °C for assay of total antioxidant capacity (TAC) (Cat. No. TA 25 13, Biodiagnostics) and malondialdehyde (MDA) (Cat. No. MD 25 29, Biodiagnostics).

Techniques: Western Blot, Expressing, Comparison, Control

TNF-α, TAC and TOC levels in SHAM, EXP, HI and HI/EXP groups. (a) * p < 0.0001, HI vs. SHAM; ** p < 0.001, HI vs. EXP; # p < 0.0001 HI/EXP vs. SHAM and EXP; ## p < 0.01, HI/EXP vs. HI. (b) * P < 0.0001, HI vs. SHAM; ** P < 0.01, HI vs. EXP; # P < 0.0001 HI/EXP vs. SHAM and EXP; ## P < 0.01 HI/EXP vs. HI (c) * p < 0.001, HI vs. SHAM; ** p < 0.01, HI vs. EXP; # p < 0.0001, HI/EXP vs. SHAM and EXP; ## P < 0.01, HI/EXP vs. HI. TNF-α (Tumour necrosis factor α), TAC (Total antioxidant capacity), TOC (Total oxidant capacity), EXP (exposure), HI (hypoxia-ischemia), HI/EXP (hypoxia-ischemia/exposure).

Journal: Toxicology Reports

Article Title: Effects of prenatal mobile phone radiation exposure on MMP9 expression: Implications for inflammation, oxidative stress, and sensory-motor impairment after neonatal hypoxia- ischemia in rats

doi: 10.1016/j.toxrep.2023.10.007

Figure Lengend Snippet: TNF-α, TAC and TOC levels in SHAM, EXP, HI and HI/EXP groups. (a) * p < 0.0001, HI vs. SHAM; ** p < 0.001, HI vs. EXP; # p < 0.0001 HI/EXP vs. SHAM and EXP; ## p < 0.01, HI/EXP vs. HI. (b) * P < 0.0001, HI vs. SHAM; ** P < 0.01, HI vs. EXP; # P < 0.0001 HI/EXP vs. SHAM and EXP; ## P < 0.01 HI/EXP vs. HI (c) * p < 0.001, HI vs. SHAM; ** p < 0.01, HI vs. EXP; # p < 0.0001, HI/EXP vs. SHAM and EXP; ## P < 0.01, HI/EXP vs. HI. TNF-α (Tumour necrosis factor α), TAC (Total antioxidant capacity), TOC (Total oxidant capacity), EXP (exposure), HI (hypoxia-ischemia), HI/EXP (hypoxia-ischemia/exposure).

Article Snippet: Finally, TNF-α, Total antioxidant capacity (TAC), and total oxidant capacity (TOC) were measured using specific kits (all kits obtained from Zellbio, Germany).

Techniques: Hi-C